Vestor Capital’s TRANSITION THERAPEUTICS INC (CANADA) TTHI Stock Holding History

Vestor Capital’s Portfolio TTHI Stock Details TTHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-42,600	Closed	-$55K	–	94
2016 Q1	$55K	Hold	42,600	–	–	0.02%	83
2015 Q4	$81K	Hold	42,600	–	–	0.02%	80
2015 Q3	$75K	Hold	42,600	–	–	0.02%	82
2015 Q2	$89K	Hold	42,600	–	–	0.03%	78
2015 Q1	$291K	Hold	42,600	–	–	0.1%	55
2014 Q4	$290K	Hold	42,600	–	–	0.08%	66
2014 Q3	$294K	Hold	42,600	–	–	0.1%	60
2014 Q2	$286K	Hold	42,600	–	–	0.1%	61
2014 Q1	$340K	Hold	42,600	–	–	0.12%	62
2013 Q4	$242K	Hold	42,600	–	–	0.09%	68
2013 Q3	$174K	Hold	42,600	–	–	0.07%	68
2013 Q2	$138K	Buy	+42,600	New	+$121K	0.06%	61

Other funds holding TTHI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HCM

Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

FNBT

FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return

NBW Capital Boston, Massachusetts $464M AUM 21.25% 1-Year Est. Return

KAM

Kassirer Asset Management Toronto, Ontario, Canada $4.07M AUM 49.71% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Vestor Capital's TTHI Position: Q2 2016 in Review

Vestor Capital sold out of TRANSITION THERAPEUTICS INC (CANADA) (TTHI) in Q2 2016, closing a stake of 42,600 shares — an estimated $55K sold.

Vestor Capital first reported a position in TTHI in Q2 2013 and held it in 12 quarters. The position peaked at $340K in Q1 2014. 20 funds tracked by Wall St. Rank hold TTHI as of Q2 2016.

Vestor Capital reported no remaining TRANSITION THERAPEUTICS INC (CANADA) position as of Q2 2016 after selling out during the quarter.
Vestor Capital sold 42,600 TRANSITION THERAPEUTICS INC (CANADA) shares in Q2 2016, an estimated $55K.
Vestor Capital first reported a position in TRANSITION THERAPEUTICS INC (CANADA) in Q2 2013 and held it in 12 quarters.
Vestor Capital's TRANSITION THERAPEUTICS INC (CANADA) position peaked at $340K in Q1 2014.
20 funds tracked by Wall St. Rank held TRANSITION THERAPEUTICS INC (CANADA) as of Q2 2016.

Based on Vestor Capital's 13F filing for Q2 2016, filed 9 Aug 2016.